24/7 Market News Snapshot 31 July, 2025 – InspireMD, Inc. (NASDAQ:NSPR)
DENVER, Colo., 31 July, 2025 (www.247marketnews.com) – (Nasdaq:NSPR) are discussed in this article.
InspireMD, Inc. (Nasdaq:NSPR) has demonstrated significant upward momentum in the financial markets, with shares trading at $2.80, reflecting an 18.14% increase from the prior session close of $2.37. Since opening at $2.43, the stock’s trading activity, with a volume of 529.55K shares, indicates strong investor interest and positions the company for potential further gains. Technical indicators suggest that the stock is approaching resistance levels around $2.85, while support is forming near $2.50. A continuation of robust trading volume could sustain this positive trend, presenting an opportunity for investors focused on growth in the biotech sector.
In a landmark achievement, InspireMD has raised approximately $58 million through a strategic equity private placement (PIPE) and the exercise of warrants, following the recent approval of its CGuard® Prime carotid stent system by the U.S. Food and Drug Administration (FDA). The PIPE financing secured around $40.1 million from both existing and new investors, led by OrbiMed and Marshall Wace, by issuing roughly 16.56 million shares at $2.42 per share. Additionally, $17.9 million was raised through warrants triggered by the FDA approval.
CEO Marvin Slosman emphasized that this funding is essential for launching CGuard Prime in the U.S. market, reinforcing InspireMD’s commitment to growth and enhancing its balance sheet to support commercialization efforts. The raised capital will be allocated toward key operations, including sales, marketing, and research and development.
In conjunction with the PIPE, InspireMD will submit a registration statement for the resale of issued shares, aiming to maintain transparency and regulatory compliance. With its innovative MicroNet™ technology, InspireMD is positioned to set new standards in carotid intervention, promising to significantly impact stroke prevention and reshape market dynamics.